Close

Hospital in Italy

Leader in the production of β-lactam antibiotics and products dedicated to hospital therapies, IBI sells the products in its IBISQUS hospital line with skill and professionalism to all of the public and private health facilities in Italy.

Its in-depth knowledge of the hospital channel and its needs, together with avant-garde IT solutions and highly qualified personnel, mean that IBI can ensure top quality and efficient distribution.

Search in the product catalogue

IBIGEN ZOLEDRONIC ACID

Medicines for the treatment of bone diseases, bisphosphonates - ATC code: M05BA08

Terapia Osteomodulanti
Acido Zoledronico
AMOXYCILLIN AND IBIGEN CLAVULAN ACID

Pharmacotherapeutic group: Association of penicillins, including beta-lactamase inhibitors - ATC Code: J01CR02

Antibiotici
Amoxicillina e Acido Clavulanico
AMPICILLINA AND SULBACTAM IBI

Pharmacotherapeutic group: Antibacterial for systemic use - ATC Code: J01CR01

Antibiotici
Ampicillina+Sulbactam
ATOSIBAN IBISQUS

Pharmacotherapeutic group: Other gynecological, ATC code: G02CX01

Ginecologia
atosiban acetato
BICALUTAMIDE IBIGEN

Pharmacotherapeutic group: antiandrogens - ATC code: L02BB03

Antineoplastici
Bicalutamide
CEFOTAXIME IBI

Categoria farmacoterapeutica: Antiinfettivi, cefalosporine - Codice ATC: J01DD01

Antibiotici
Cefotaxime Sodico
CIPROFLOXACINA IBIGEN

Pharmacotherapeutic group: Fluoroquinolones, ATC code: J01MA02

Antibiotici
Ciprofloxacina
CLINDAMICINA IBI

Pharmacotherapeutic group: antibacterials for systemic use. ATC code: J01FF01

Antibiotici
Clindamicina Fosfato
CLOFARABINA IBISQUS

Pharmacotherapeutic group: antineoplastic agents, antimetabolites, purine analogs - ATC Code L01BB06

Agenti antineoplastici
Clofarabina
EDEVEN C.M. GEL

Pharmacotherapeutic group: drugs for topical use, for joint and muscular pain - ATC Code: M02AC

Infiammazione/Edema
Escina+Dietilamina Salicilato
EDEVEXIN

Pharmacotherapeutic group: vasoprotectors - capillaroprotective substances - ATC Code C05CX

Infiammazione/Edema
Escina
GABESATO MESILATO IBI

Pharmacotherapeutic group: Antihaemorrhagics, antifibrinolytics, protease inhibitors - ATC Code: B02AB

Antiproteasico
Gabesato Mesilato
IBIFEN

Pharmacotherapeutic group: non-steroidal anti-inflammatory/antirheumatic drugs - ATC code: M01AE03Pharmacotherapeutic group: non-steroidal anti-inflammatory for topical use - ATC Code M02AA10

Infiammazione/Edema
Ketoprofene
IBITAZINA

Pharmacotherapeutic group: Antibacterials for systemic use. Association of penicillins and beta-lactamase inhibitors - ATC Code: J01CR05

Antibiotici
Piperacillina+Tazobactam
IBIXACIN

Pharmacotherapeutic group: Fluoroquinolones - ATC Code: J01MA02

Antibiotici
Ciprofloxacina
METEOSIM

Pharmacotherapeutic group: other drugs for functional bowel disorders - ATC Code: A03AX13

Gastroenterelogica
Simeticone
MIDAZOLAM IBI

Pharmacotherapeutic group: Hypnotics and sedatives (benzodiazepine derivatives) - ATC Code: N05CD08

Anestesiologica
Midazolam
PIPERACILLINA E TAZOBACTAM IBIGEN

Pharmacotherapeutic group: Antibacterials for systemic use. Association of penicillins and beta-lactamase inhibitors - ATC-Code: J01CR05

Antibiotici
Piperacillina+Tazobactam
PIPERITAL

Pharmacotherapeutic group: Antibacterials for systemic use - ATC Code: J01CA12

Antibiotici
Piperacillina
PROPOFOL IBI

Pharmacotherapeutic group: other general anaesthetics - ATC code: N01AX10

Anestesiologica
Propofol
SIMETICONE IBI

Pharmacotherapeutic group: other drugs for functional bowel disorders - ATC Code: A03AX13

Gastroenterelogica
Simeticone
SIROCTID

Pharmacotherapeutic group: Somatostatin and analogs - ATC code: H01CB02

Ormoni Ipotalamici
Octreotide
TIROFIBAN IBISQUS

Pharmacotherapeutic group: Blood and hematopoietic organs - antithrombotic - antiplatelet agents, excluding heparin - ATC code: B01A C17

Cardiologica
Tirofiban
TOBRAMICINA IBI

Pharmacotherapeutic group: antibacterials for systemic use - ATC Code: J01GB01

Antibiotici
Tobramicina
URSILON

Pharmacotherapeutic group: Preparations based on bile acids - ATC Code A05AA02

Gastroenterelogica
Acido Ursodesossicolico

Thank you

We sent you an email. To activate the newsletter click on the link you will find in the message, thank you!

Sign up for the newsletter


Dichiarazione in merito al GDPR (Regolamento Generale Protezione dei Dati)

In caso di sottoscrizione Newsletter dovrai confermare l’iscrizione per mezzo di mail di conferma inviata all’indirizzo inserito. In tal caso il trattamento prevede:

la profilazione dell’utente in gruppi, status, preferenze secondo quanto indicato e dedotto dalle informazioni inviate tramite il form o successiva autonoma profilazione.
l’utilizzo del dato per l’invio di comunicazione a mezzo digitale (email, whatsapp) e non (cartaceo) avente scopo informativo/commerciale.
l'utilizzo della mail per la generazione di campagne marketing e informative personalizzate, digitali e non.

Cancel
CHIUDI

This is a title
and this is still a title


Lorem ipsum dolor sit amet, consectetur adipisci elit, sed eiusmod tempor incidunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi Lorem ipsum dolor sit amet, consectetur adipisci elit, sed eiusmod tempor incidunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi Lorem ipsum dolor sit amet, consectetur adipisci elit, sed eiusmod tempor incidunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi Lorem ipsum dolor sit amet, consectetur adipisci elit, sed eiusmod tempor incidunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi

Lorem ipsum dolor sit amet, consectetur adipisci elit, sed eiusmod tempor incidunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi

Private area


Log in to restricted area


Registration


Notice on the treatment of personal data

Dear visitor, in the following sections we will describe how the reserved area of the www.ibi-lorenzini.it website is managed as far as processing personal data of users. The notice is issued pursuant to art. 13 of EU Regulation 679/2016 (hereinafter also the Regulation) on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and applies to those who interact with the website of Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. (hereinafter I.B.I.), which can be accessed at the following address: www.ibi-lorenzini.it, the opening page of the official I.B.I. website. The notice only applies to the I.B.I. website. It does not apply to any other websites that the user may access through links.

  1. The processing of the personal data that you supply, which are also used for the creation of your user profile, and which will be included in the “Doctors’ Details” database, has the following purposes:
  • carry out medical sales related activities for drugs for human consumption. Istituto Biochimico Italiano Giovanni Lorenzini S.p.A. and Ibigen S.r.l., part of the same company group (hereinafter also Ibigen Group), carry out such activities in compliance with the provisions of the current regulations, with particular, but not exclusive, attention to Italian Legislative Decree no. 219 of 24.04.2006 and subsequent modifications. In view of the objectives of the Ibigen Group, it is important to point out that the processing activities do not deal with any special data. The supply of the data for the medical sales activities is necessary, and failure to provide consent will make it impossible for us to fulfil the above objectives;

  • forwarding of invitations or information on congresses, conferences, seminars, communications on initiatives promoted or sponsored by the Ibigen group, regular or occasional publications, information on new products, methods and services. Such activities are carried out by e-mail, fax, SMS, normal post or telephone. The supply of the data for such purposes is optional, and failure to supply them will result in the information not being forwarded.

  1. As far as the creation of your profile on our website, we remind you that your password is strictly confidential and should not be disclosed.
  2. Your data will not be disclosed, but may be shared with individuals, companies, associations or professional studios providing support or consultancy services to the Ibigen Group, the medical sales representative network, our suppliers and any sub-suppliers - from time to time entrusted with activities connected with the above objectives -, mailing or statistical survey companies, or companies for the forwarding of scientific documentation, and individuals authorised to access the data by law and/or pursuant to secondary regulations.
  3. Such people may only acquire knowledge of your personal data for the above mentioned purposes.
  4. The Owners of the Treatment (Data Controllers) are the two companies of the Ibigen Group with legal headquarters at Via Fossignano no. 2, Aprilia (LT), Italy.
  5. Personal data are processed using manual and automated means, for the time necessary for reaching the objectives for which they were collected. Special safety measures are in place to avoid data loss, unlawful or incorrect use and unauthorised access.
  6. Lastly, we also inform you that you can at any time exercise the rights contemplated by the Regulation, and in particular request access to the data, their correction, update and block, or you can withdraw your consent, or request the limitation of the processing or the cancellation of the data. As data subject, you also have the right to issue a complaint with the relevant control Authority. Such rights may be exercised in writing to the following e-mail address: info@ibi-lorenzini.com.
  7. The Data Protection Officer may be contacted at the following e-mail address: dpo_ibi@protectiontrade.it

* Required fields
Cancel